Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.94 +0.07 (+1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Long-Term Debt Repayments (2023 - 2024)

Updated

Unicycive Therapeutics (UNCY) reported Long-Term Debt Repayments of $496,000 for Q1 2024, up 106.7% from $240,000 a year earlier and up 142.0% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Long-Term Debt Repayments (2023 - 2024) Analysis & Trends

Over the twelve months ended Mar 31, 2024, Unicycive Therapeutics' Long-Term Debt Repayments came in at $752,000.

  • By year, Long-Term Debt Repayments came in at $482,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Unicycive Therapeutics 109.75 Mn -90.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 496,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 51,000.00
Mar 31, 2023 240,000.00
API Access

Unicycive Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=UNCY&period=max&api_key=YOUR_API_KEY